In the "Completion of Healing" session, nutritional medical approaches dealing with sleep disorders and chronic diseases were presented, and in the "Lifestyle Modification: Mind and Behavior" session, healing strategies were presented through improvements in overall life such as digital cognitive behavioral therapy, cancer metabolism management, and exercise habit protocols. Participants reaffirmed the importance of metabolic and nutritional control as the basis for treating diseases and actively discussed practical application plans in the clinical field.
Prodizen developed and commercialized PRP (self-blood-rich plasma) tubes for the first time in Korea and has been steadily supplying them to the medical field for more than 15 years since 2008, suggesting clinical synergy that can be obtained when nutritional medicine and regenerative therapy are combined, focusing on its flagship regenerative medicine solution "GFC+" at this conference.
GFC+ is a high-purity PRP (self-platelet plasma) technology that can be applied to various procedures such as skin elasticity, pigment, scarring, and hair regeneration by extracting and activating growth factors in platelets at a high concentration. It has improved the limitations of existing PRP by enabling uniform growth factor concentration, high cell reactivity, and systemic application, and has simultaneously demonstrated tissue recovery rate and procedure stability through a number of clinical data.
At the conference site, medical staff directly looked at the cell regeneration mechanism and clinical application cases of GFC+, and showed high interest in integrated solutions that can be used in overall anti-aging routines such as improving skin elasticity, pigment relief, scar treatment, and hair regeneration.
An official from Prodizen said, "The key to anti-aging is not just to slow down aging, but to induce recovery and regeneration at the cell level. Prodizen has focused on developing technologies that increase the precision and stability of extracting growth factors. Through participation in this academic conference, we wanted to share the scientific basis and clinical value of GFC+ and new treatment directions that regenerative medicine can create with nutritional medicine."
Prodizen is solidifying its global position by obtaining regulatory certification in major international markets based on its regenerative medicine technology, including GFC+. It has been recognized for its technology and quality in major countries such as Canada and China, as well as CE and FDA certification, and is expanding its export networks to Asia, Europe, and North America based on this. It is also positioned as a leading company in global standards in the field of regenerative medicine through continuous R&D and technological innovation.
[Bio-Times = Reporter Jung Min-koo] news@biotimes.co.kr
이전글
다음글